Delivery Order SPE2DB24D2013-SPE2DB25FCJMF
- Not listed
- The Defense Logistics Agency awarded a $1,353.29 delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 40 mg capsules (30-count) on August 21, 2025, with completion expected by August 22, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a single pharmaceutical supply transaction executed under AmerisourceBergen's larger federal contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count packages) with a ceiling value of $9,373.09. This is a firm fixed-price delivery order with no set-aside designation, completed competitively through open procurement. The order is scheduled for completion by August 21, 2025, with performance to take place at AmerisourceBergen's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count) with a ceiling value of $1,011.63. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is set for ultimate completion on July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,537.02 to AmerisourceBergen Drug Corp for Carvedilol ER 20 mg capsules (30-count units) on June 16, 2025, with completion scheduled for June 17, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award based on capability demonstration. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count) with a contract ceiling value of $2,339.36. This is a firm fixed-price delivery order with no set-aside designation, executed through open competition. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract has an ultimate completion date...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count) with a ceiling value of $4,048.75. This delivery order represents a firm fixed price contract with no set-aside designation, indicating it was awarded through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,736.21 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units). This firm fixed price contract, which is not set-aside and was competitively awarded, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The order is scheduled for completion by September 4, 2025, with performance at AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count packaging) with a ceiling value of $10,683.54. This is a firm fixed-price delivery order with an ultimate completion date of September 9, 2025, and was competitively awarded without set-aside provisions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $7,150.73 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 40 mg capsules (30-count) on August 19, 2025, with an ultimate completion date of August 20, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be conducted at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Carvedilol ER 40 mg capsules in quantities of 30 units. This competitive award, valued at $6,939.84, carries a firm fixed price and is scheduled for completion by September 30, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award falls under AmerisourceBergen's larger...
- SPE2DB24D2013Indefinite Delivery Contract
- SPE2DB24D2013-SPE2DB25FCJMFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 20 mg capsules (30-count) on June 26, 2025, with a ceiling value of $1,413.80 and a firm fixed price structure. This delivery order, which is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX, valued at $999.99M through December 2026), represents a routine pharmaceutical supply transaction executed through open competition without set-aside designation. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 27, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supply vendor, regularly fulfills delivery orders for a comprehensive range of medications and medical supplies supporting military and veteran healthcare systems. As a prime vendor under DLA's pharmaceutical supply chain, the company demonstrates capability to meet federal procurement requirements across multiple therapeutic domains. This specific delivery order for the cardiovascular medication Carvedilol exemplifies the routine, competitively awarded transactions that occur under the company's larger umbrella contract vehicle, which enables flexible pharmaceutical sourcing for Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 6/26/25 |